Search research articles
Contact Us
Filters
Showing results (91-100 of 269) with videos related to
Page
of 27
Sort By:
Cardio-Oncology (London, England)
|
February 3, 2021
Rationale for setting up a cardio-oncology unit: our experience at Mayo Clinic
Sergio Barros-Gomes, Joerg Herrmann, Sharon L Mulvagh, et al.
Journal of the American Society of Nephrology : JASN
|
February 18, 2005
Effects of proteasome inhibition on the kidney in experimental hypercholesterolemia
Alejandro R Chade, Joerg Herrmann, Xiangyang Zhu, et al.
Mayo Clinic Proceedings
|
September 7, 2014
Evaluation and management of patients with heart disease and cancer: cardio-oncology
Joerg Herrmann, Amir Lerman, Nicole P Sandhu, et al.
Mayo Clinic Proceedings
|
August 8, 2015
Complicated and Advanced Atherosclerosis in a Young Woman With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Success and Challenges of BCR/ABL1-Targeted Cancer Therapy
Joerg Herrmann, Malcolm R Bell, Rebekkah L Warren, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
December 11, 2025
Vascular Toxicities of Cancer Therapies: 2025 Update
Teodora Donisan, Dinu V Balanescu, Jun-Ichi Abe, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
February 27, 2009
Phase-contrast MRI-based elastography technique detects early hypertensive changes in ex vivo porcine aortic wall
David A Woodrum, Joerg Herrmann, Amir Lerman, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 13, 2025
Incidence and Outcomes of Atrial Arrhythmia with CDK4/6 Inhibitors in HR-Positive / HER2-Negative Breast Cancer
Nathaniel E Davis, Joerg Herrmann, David O Hodge, et al.
Plos One
|
October 14, 2014
The association between circulating microRNA levels and coronary endothelial function
R Jay Widmer, Woo-Young Chung, Joerg Herrmann, et al.
International Journal of Cardiology
|
March 28, 2026
Incidence and outcomes of atrial arrhythmia with cyclin dependent kinase 4/6 inhibitors in hormone receptor-positive / human epidermal growth factor receptor 2-negative breast cancer
Nathaniel E Davis, Joerg Herrmann, David O Hodge, et al.
Journal of the American College of Cardiology
|
May 3, 2002
Chronic endothelin receptor antagonism prevents coronary vasa vasorum neovascularization in experimental hypercholesterolemia
Joerg Herrmann, Patricia J Best, Erik L Ritman, et al.
Page
of 27
Search research articles
Search
Showing results (91-100 of 269) with videos related to
Sort By:
Page
of 27
Cardio-Oncology (London, England)
|
February 3, 2021
Rationale for setting up a cardio-oncology unit: our experience at Mayo Clinic
Sergio Barros-Gomes, Joerg Herrmann, Sharon L Mulvagh, et al.
Journal of the American Society of Nephrology : JASN
|
February 18, 2005
Effects of proteasome inhibition on the kidney in experimental hypercholesterolemia
Alejandro R Chade, Joerg Herrmann, Xiangyang Zhu, et al.
Mayo Clinic Proceedings
|
September 7, 2014
Evaluation and management of patients with heart disease and cancer: cardio-oncology
Joerg Herrmann, Amir Lerman, Nicole P Sandhu, et al.
Mayo Clinic Proceedings
|
August 8, 2015
Complicated and Advanced Atherosclerosis in a Young Woman With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Success and Challenges of BCR/ABL1-Targeted Cancer Therapy
Joerg Herrmann, Malcolm R Bell, Rebekkah L Warren, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
December 11, 2025
Vascular Toxicities of Cancer Therapies: 2025 Update
Teodora Donisan, Dinu V Balanescu, Jun-Ichi Abe, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
February 27, 2009
Phase-contrast MRI-based elastography technique detects early hypertensive changes in ex vivo porcine aortic wall
David A Woodrum, Joerg Herrmann, Amir Lerman, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 13, 2025
Incidence and Outcomes of Atrial Arrhythmia with CDK4/6 Inhibitors in HR-Positive / HER2-Negative Breast Cancer
Nathaniel E Davis, Joerg Herrmann, David O Hodge, et al.
Plos One
|
October 14, 2014
The association between circulating microRNA levels and coronary endothelial function
R Jay Widmer, Woo-Young Chung, Joerg Herrmann, et al.
International Journal of Cardiology
|
March 28, 2026
Incidence and outcomes of atrial arrhythmia with cyclin dependent kinase 4/6 inhibitors in hormone receptor-positive / human epidermal growth factor receptor 2-negative breast cancer
Nathaniel E Davis, Joerg Herrmann, David O Hodge, et al.
Journal of the American College of Cardiology
|
May 3, 2002
Chronic endothelin receptor antagonism prevents coronary vasa vasorum neovascularization in experimental hypercholesterolemia
Joerg Herrmann, Patricia J Best, Erik L Ritman, et al.
Page
of 27